Masahiro Ono

57PUBLICATIONS
18CO-AUTHORS
NanophotonicsPharmacogenomicsBiomedical imagingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Oct 23, 2026
Development of Novel 211At-Labeled Agent for Neurotensin Receptor 1-Targeted α-Particle Therapy.

|Jul 14, 2026
Improving Pharmacokinetics of PSMA/GRPR-Targeting Radiolabeled Heterodimer through Enhanced Albumin Binding.

|Jun 30, 2026
Bithiophene Scaffold for PET Imaging and Photosensitization as a Novel Theranostic Platform Targeting Amyloid-β Aggregates.

|Jun 23, 2026
Systematic Investigation of Fatty Acids with Different Carbon-Chain Length as Albumin Binder to Improve Tumor Accumulation of Radioligands.

|Jun 18, 2026
Head-to-Head Comparison of Monomeric, Homodimeric, and Heterodimeric Fibroblast Activation Protein-Targeting Radioligands Based on Small Molecule Inhibitor and Cyclic Peptide.

|Jun 12, 2026
Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient 111In/177Lu Theranostics.

Pageof 10

Frequent Collaborators

45 joint publications

Hiroyuki Watanabe

17 joint publications

Kazuma Nakashima

12 joint publications

Shimpei Iikuni

5 joint publications

Hideo Saji